Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017 (2017), Article ID 9207616, 7 pages
https://doi.org/10.1155/2017/9207616
Research Article

Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma

1Pathology Department, “Tzaneion” General Hospital, Pireaus, Greece
22nd Department of Surgery, University Hospital “Aretaeion”, Athens, Greece
3Division of Surgery & Interventional Science, University College London, London, UK
41st Department of Surgery, “Tzaneion” General Hospital, Pireaus, Greece

Correspondence should be addressed to Panagis M. Lykoudis; ku.ca.lcu@siduokyl.p

Received 21 August 2016; Revised 14 February 2017; Accepted 28 February 2017; Published 22 March 2017

Academic Editor: Piero Chirletti

Copyright © 2017 Despoina Myoteri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Schneider, J. T. Siveke, F. Eckel, and R. M. Schmid, “Pancreatic cancer: basic and clinical aspects,” Gastroenterology, vol. 128, no. 6, pp. 1606–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Vincent, J. Herman, R. Schulick, R. H. Hruban, and M. Goggins, “Pancreatic cancer,” The Lancet, vol. 378, no. 9791, pp. 607–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Yi, A. A. Guzzetta, V. J. Bailey et al., “Novel methylation biomarker panel for the early detection of pancreatic cancer,” Clinical Cancer Research, vol. 19, no. 23, pp. 6544–6555, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Bhatti, O. Peacock, A. K. Awan, D. Semeraro, M. Larvin, and R. I. Hall, “Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma,” World Journal of Surgery, vol. 34, no. 4, pp. 768–775, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Ansari, A. Rosendahl, J. Elebro, and R. Andersson, “Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer,” The British Journal of Surgery, vol. 98, no. 8, pp. 1041–1055, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Smith, J. Tang, C. Tudur-Smith, J. P. Neoptolemos, and P. Ghaneh, “Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer,” British Journal of Cancer, vol. 104, no. 9, pp. 1440–1451, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Ben, J. Zheng, J. Fei et al., “High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma,” Pancreas, vol. 43, no. 5, pp. 744–749, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. R. Niveditha and P. Bajaj, “Vimentin expression in breast carcinomas,” Indian Journal of Pathology & Microbiology, vol. 46, no. 4, pp. 579–584, 2003. View at Google Scholar
  9. W. Domagala, L. Wozniak, J. Lasota, K. Weber, and M. Osborn, “Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas,” The American Journal of Pathology, vol. 137, no. 5, pp. 1059–1064, 1990. View at Google Scholar
  10. A. Hemalatha, T. N. Suresh, and M. L. Kumar, “Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters,” Indian Journal of Cancer, vol. 50, no. 3, pp. 189–194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Xiaoping, Z. Xiaowei, Z. Leizhen, and G. Weijian, “Expression and significance of CD44 and p-AKT in pancreatic head cancer,” World Journal of Surgical Oncology, vol. 13, no. 1, p. 334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Hanninen, M. Salmi, O. Simell, and S. Jalkanen, “Endothelial cell-binding properties of lymphocytes infiltrated into human diabetic pancreas. Implications for pathogenesis of IDDM,” Diabetes, vol. 42, no. 11, pp. 1656–1662, 1993. View at Publisher · View at Google Scholar
  13. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: a Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Goggins, “Markers of pancreatic cancer: working toward early detection,” Clinical Cancer Research, vol. 17, no. 4, pp. 635–637, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Leader, M. Collins, J. Patel, and K. Henry, “Vimentin: an evaluation of its role as a tumour marker,” Histopathology, vol. 11, no. 1, pp. 63–72, 1987. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Fuchs and K. Weber, “Intermediate filaments: structure, dynamics, function, and disease,” Annual Review of Biochemistry, vol. 63, no. 1, pp. 345–382, 1994. View at Publisher · View at Google Scholar
  17. L. K. Liu, X. Y. Jiang, X. X. Zhou, D. M. Wang, X. L. Song, and H. B. Jiang, “Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome,” Modern Pathology, vol. 23, no. 2, pp. 213–224, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Satelli and S. Li, “Vimentin in cancer and its potential as a molecular target for cancer therapy,” Cellular and Molecular Life Sciences, vol. 68, no. 18, pp. 3033–3046, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. W. Klymkowsky and P. Savagner, “Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe,” The American Journal of Pathology, vol. 174, no. 5, pp. 1588–1593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. A. Iacobuzio-Donahue, B. Fu, S. Yachida et al., “DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer,” Journal of Clinical Oncology, vol. 27, no. 11, pp. 1806–1813, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Handra-Luca, S. M. Hong, K. Walter, C. Wolfgang, R. Hruban, and M. Goggins, “Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas,” British Journal of Cancer, vol. 104, no. 8, pp. 1296–1302, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Ohara, T. Oda, M. Sugano et al., “Histological and prognostic importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer,” Cancer Science, vol. 104, no. 8, pp. 1127–1134, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. R. J. Sneath and D. C. Mangham, “The normal structure and function of CD44 and its role in neoplasia,” Molecular Pathology, vol. 51, no. 4, pp. 191–200, 1998. View at Publisher · View at Google Scholar
  24. J. Ringel, R. Jesnowski, C. Schmidt et al., “CD44 in normal human pancreas and pancreatic carcinoma cell lines,” Teratogenesis, Carcinogenesis, and Mutagenesis, vol. 21, no. 1, pp. 97–106, 2001. View at Publisher · View at Google Scholar
  25. Y. Chen, Z. Fu, S. Xu, Y. Xu, and P. Xu, “The prognostic value of CD44 expression in gastric cancer: a meta-analysis,” Biomedicine & Pharmacotherapy, vol. 68, no. 6, pp. 693–697, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Zhao, J. L. He, Z. X. Qiu et al., “Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 16, pp. 6761–6766, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Naor, S. B. Wallach-Dayan, M. A. Zahalka, and R. V. Sionov, “Involvement of CD44, a molecule with a thousand faces, in cancer dissemination,” Seminars in Cancer Biology, vol. 18, no. 4, pp. 260–267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Y. Hu, H. Liu, J. W. Zhang, K. Hu, and Y. Lin, “Clinical significance of Smac and Ki-67 expression in pancreatic cancer,” Hepato-Gastroenterology, vol. 59, no. 120, pp. 2640–2643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. O. H. Wang, N. Azizian, M. Guo et al., “Prognostic and functional significance of MAP4K5 in pancreatic cancer,” PLoS One, vol. 11, no. 3, article e0152300, 2016. View at Publisher · View at Google Scholar · View at Scopus